Immunogenetics of autoimmune thyroid diseases: A comprehensive review

Jacobson, 1997, Epidemiology and estimated population burden of selected autoimmune diseases in the United States, Clin. Immunol. Immunopathol., 84, 223, 10.1006/clin.1997.4412 Antonelli, 2015, Autoimmune thyroid disorders, Autoimmun. Rev., 14, 174, 10.1016/j.autrev.2014.10.016 Tomer, 2014, Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics, Annu. Rev. Pathol., 9, 147, 10.1146/annurev-pathol-012513-104713 Villanueva, 2003, Sibling recurrence risk in autoimmune thyroid disease, Thyroid Off. J. Am. Thyroid Assoc., 13, 761, 10.1089/105072503768499653 Tomer, 2003, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function, Endocr. Rev., 24, 694, 10.1210/er.2002-0030 Hall, 1967, Familial studies of autoimmune thyroiditis, Clin. Exp. Immunol., 2, 719 Brix, 1998, A population-based study of Graves' disease in Danish twins, Clin. Endocrinol., 48, 397, 10.1046/j.1365-2265.1998.00450.x Brix, 2012, Twin studies as a model for exploring the aetiology of autoimmune thyroid disease, Clin. Endocrinol., 76, 457, 10.1111/j.1365-2265.2011.04318.x Brix, 2001, Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts, J. Clin. Endocrinol. Metab., 86, 930 McLeod, 2015, Race/Ethnicity and the prevalence of thyrotoxicosis in young americans, Thyroid Off. J. Am. Thyroid Assoc., 25, 621, 10.1089/thy.2014.0504 Dechairo, 2005, Association of the TSHR gene with Graves' disease: the first disease specific locus, Eur. J. Hum. Genet. EJHG, 13, 1223, 10.1038/sj.ejhg.5201485 Brand, 2009, Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease, Hum. Mol. Genet., 18, 1704, 10.1093/hmg/ddp087 Chu, 2011, A genome-wide association study identifies two new risk loci for Graves' disease, Nat. Genet., 43, 897, 10.1038/ng.898 Ploski, 2010, Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts, PLoS One, 5, e15512, 10.1371/journal.pone.0015512 Tomer, 2013, Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes, J. Clin. Endocrinol. Metab., 98, E144, 10.1210/jc.2012-2408 Stefan, 2014, Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity, Proc. Natl. Acad. Sci. U. S. A., 111, 12562, 10.1073/pnas.1408821111 Colobran, 2011, Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance, Hum. Mol. Genet., 20, 3415, 10.1093/hmg/ddr247 Allan, 2005, The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs, J. Clin. Invest., 115, 3276, 10.1172/JCI24685 Kaufmann, 1996, Five years on the wings of fork head, Mech. Dev., 57, 3, 10.1016/0925-4773(96)00539-4 Brunkow, 2001, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, Nat. Genet., 27, 68, 10.1038/83784 Schubert, 2001, Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation, J. Biol. Chem., 276, 37672, 10.1074/jbc.M104521200 Wu, 2006, FOXP3 controls regulatory T cell function through cooperation with NFAT, Cell, 126, 375, 10.1016/j.cell.2006.05.042 Marson, 2007, Foxp3 occupancy and regulation of key target genes during T-cell stimulation, Nature, 445, 931, 10.1038/nature05478 Zheng, 2007, Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells, Nature, 445, 936, 10.1038/nature05563 Ono, 2007, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1, Nature, 446, 685, 10.1038/nature05673 Camperio, 2012, Forkhead transcription factor FOXP3 upregulates CD25 expression through cooperation with RelA/NF-kappaB, PLoS One, 7, e48303, 10.1371/journal.pone.0048303 Maloy, 2001, Regulatory T cells in the control of immune pathology, Nat. Immunol., 2, 816, 10.1038/ni0901-816 Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol. Rev., 182, 18, 10.1034/j.1600-065X.2001.1820102.x Chatila, 2000, JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome, J. Clin. Invest., 106, R75, 10.1172/JCI11679 Bennett, 2001, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat. Genet., 27, 20, 10.1038/83713 Wildin, 2001, X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy, Nat. Genet., 27, 18, 10.1038/83707 Wildin, 2005, IPEX and FOXP3: clinical and research perspectives, J. Autoimmun., 56, 10.1016/j.jaut.2005.04.008 Katoh, 2013, FOXP3: genetic and epigenetic implications for autoimmunity, J. Autoimmun., 41, 72, 10.1016/j.jaut.2012.12.004 Ban, 2007, The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts, J. Autoimmun., 28, 201, 10.1016/j.jaut.2007.02.016 Inoue, 2010, Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases, Clin. Exp. Immunol., 162, 402, 10.1111/j.1365-2249.2010.04229.x Villano, 2009, Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families, J. Clin. Endocrinol. Metab., 94, 1458, 10.1210/jc.2008-2193 Jenkins, 2002, Disease associations with autoimmune thyroid disease, Thyroid Off. J. Am. Thyroid Assoc., 12, 977, 10.1089/105072502320908312 Pagani, 2000, Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element, J. Biol. Chem., 275, 21041, 10.1074/jbc.M910165199 Gabellini, 2001, A polymorphic GT repeat from the human cardiac Na+Ca2+ exchanger intron 2 activates splicing, Eur. J. Biochem. FEBS, 268, 1076, 10.1046/j.1432-1327.2001.01974.x Li, 2015, Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis, Gene, 556, 142, 10.1016/j.gene.2014.11.064 Cerosaletti, 2013, Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients, PLoS One, 8, e83811, 10.1371/journal.pone.0083811 Bayer, 2005, Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period, J. Exp. Med., 201, 769, 10.1084/jem.20041179 Brand, 2007, Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs, Clin. Endocrinol., 66, 508 Cooper, 2012, Seven newly identified loci for autoimmune thyroid disease, Hum. Mol. Genet., 21, 5202, 10.1093/hmg/dds357 Chistiakov, 2011, A variant of the Il2ra/Cd25 gene predisposing to graves' disease is associated with increased levels of soluble interleukin-2 receptor, Scand. J. Immunol., 74, 496, 10.1111/j.1365-3083.2011.02608.x Reiser, 1996, Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases, N. Engl. J. Med., 335, 1369, 10.1056/NEJM199610313351807 Teft, 2006, A molecular perspective of CTLA-4 function, Annu. Rev. Immunol., 24, 65, 10.1146/annurev.immunol.24.021605.090535 Munroe, 2009, Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis, Semin. Immunol., 21, 283, 10.1016/j.smim.2009.05.008 Faure, 1997, Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells, Clin. Immunol. Immunopathol., 84, 212, 10.1006/clin.1997.4391 Toubi, 2004, The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway, Autoimmunity, 37, 457, 10.1080/08916930400002386 Bishop, 2003, The CD40-CD154 interaction in B cell-T cell liaisons, Cytokine Growth Factor Rev., 14, 297, 10.1016/S1359-6101(03)00024-8 Bishop, 2009, The many faces of CD40: multiple roles in normal immunity and disease, Semin. Immunol., 21, 255, 10.1016/j.smim.2009.08.002 Carayanniotis, 1997, Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction, Immunology, 90, 421, 10.1111/j.1365-2567.1997.00421.x Kehry, 1996, CD40-mediated signaling in B cells. Balancing cell survival, growth, and death, J. Immunol., 156, 2345, 10.4049/jimmunol.156.7.2345 Tomer, 2002, A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease, Thyroid Off. J. Am. Thyroid Assoc., 12, 1129, 10.1089/105072502321085234 Kurylowicz, 2005, Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease, Thyroid Off. J. Am. Thyroid Assoc., 15, 1119, 10.1089/thy.2005.15.1119 Ban, 2006, Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves' disease in Japanese, Thyroid Off. J. Am. Thyroid Assoc., 16, 443, 10.1089/thy.2006.16.443 Kim, 2003, A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans, Thyroid Off. J. Am. Thyroid Assoc., 13, 919, 10.1089/105072503322511319 Jacobson, 2007, A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression, Genes Immun., 8, 205, 10.1038/sj.gene.6364375 Mukai, 2005, A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese, Endocr. J., 52, 471, 10.1507/endocrj.52.471 Hsiao, 2008, Association of CD40 and thyroglobulin genes with later-onset Graves' disease in Taiwanese patients, Eur. J. Endocrinol. European Fed. Endocr. Soc., 159, 617, 10.1530/EJE-08-0410 Huber, 2012, Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease, J. Immunol., 189, 3043, 10.4049/jimmunol.1200311 Resetkova, 1996, Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice, Thyroid Off. J. Am. Thyroid Assoc., 6, 267, 10.1089/thy.1996.6.267 Jacobson, 2005, A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology, Endocrinology, 146, 2684, 10.1210/en.2004-1617 Wang, 2013, Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal, Eur. Thyroid J., 1, 251, 10.1159/000342621 Koshy, 1996, Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes, J. Clin. Invest., 98, 826, 10.1172/JCI118855 Filion, 2003, Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis, Clin. Immunol., 106, 127, 10.1016/S1521-6616(02)00028-1 Danese, 2003, Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients, Gut, 52, 1435, 10.1136/gut.52.10.1435 Park, 2007, Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE, Am. J. Respir. Crit. Care Med., 175, 775, 10.1164/rccm.200609-1286OC Fife, 2008, Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways, Immunol. Rev., 224, 166, 10.1111/j.1600-065X.2008.00662.x Brunner, 1999, CTLA-4-Mediated inhibition of early events of T cell proliferation, J. Immunol., 162, 5813, 10.4049/jimmunol.162.10.5813 Vaidya, 2002, The genetics of autoimmune thyroid disease, J. Clin. Endocrinol. Metab., 87, 5385, 10.1210/jc.2002-020492 Finck, 1994, Treatment of murine lupus with CTLA4Ig, Science, 265, 1225, 10.1126/science.7520604 Nishikawa, 1994, Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis, Eur. J. Immunol., 24, 1249, 10.1002/eji.1830240602 Knoerzer, 1995, Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig, J. Clin. Invest., 96, 987, 10.1172/JCI118146 Lenschow, 1996, CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes, Immunity, 5, 285, 10.1016/S1074-7613(00)80323-4 Donner, 1997, CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus, J. Clin. Endocrinol. Metab., 82, 143 Nithiyananthan, 2002, Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom, Thyroid Off. J. Am. Thyroid Assoc., 12, 3, 10.1089/105072502753451896 Villanueva, 2000, Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology, Thyroid Off. J. Am. Thyroid Assoc., 10, 791, 10.1089/thy.2000.10.791 Braun, 1998, CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis, Tissue Antigens, 51, 563, 10.1111/j.1399-0039.1998.tb02993.x Yanagawa, 1997, CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese, Thyroid Off. J. Am. Thyroid Assoc., 7, 843, 10.1089/thy.1997.7.843 Tomer, 2009, The etiology of autoimmune thyroid disease: a story of genes and environment, J. Autoimmun., 32, 231, 10.1016/j.jaut.2009.02.007 Yanagawa, 1995, CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population, J. Clin. Endocrinol. Metab., 80, 41 Kotsa, 1997, A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism, Clin. Endocrinol., 46, 551, 10.1046/j.1365-2265.1997.1710996.x Anjos, 2002, A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele, J. Biol. Chem., 277, 46478, 10.1074/jbc.M206894200 Ueda, 2003, Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease, Nature, 423, 506, 10.1038/nature01621 Jacobson, 2008, The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology, J. Autoimmun., 30, 58, 10.1016/j.jaut.2007.11.010 Ban, 2004, Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease, Genes Immun., 5, 203, 10.1038/sj.gene.6364059 Menconi, 2008, Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice, Proc. Natl. Acad. Sci. U. S. A., 105, 14034, 10.1073/pnas.0806584105 Simmonds, 2005, Regression mapping of association between the human leukocyte antigen region and Graves disease, Am. J. Hum. Genet., 76, 157, 10.1086/426947 Muixi, 2008, Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands, J. Immunol., 181, 795, 10.4049/jimmunol.181.1.795 Sakai, 2001, Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese, Hum. Mol. Genet., 10, 1379, 10.1093/hmg/10.13.1379 Tomer, 2003, Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families, Am. J. Hum. Genet., 73, 736, 10.1086/378588 Ban, 2003, Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease, Proc. Natl. Acad. Sci. U. S. A., 100, 15119, 10.1073/pnas.2434175100 Hodge, 2006, Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease, Thyroid Off. J. Am. Thyroid Assoc., 16, 351, 10.1089/thy.2006.16.351 Jacobson, 2009, Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective, J. Biol. Chem., 284, 34231, 10.1074/jbc.M109.041574 Liu, 2014, Identification of BACH2 as a susceptibility gene for Graves' disease in the Chinese Han population based on a three-stage genome-wide association study, Hum. Genet., 133, 661, 10.1007/s00439-013-1404-2 Muto, 1998, Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer, EMBO J., 17, 5734, 10.1093/emboj/17.19.5734 Hong, 2008, The role of Bach2 in nucleic acid-triggered antiviral innate immune responses, Biochem. Biophys. Res. Commun., 365, 426, 10.1016/j.bbrc.2007.10.183 Zhao, 2013, Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis, Hum. Mol. Genet., 22, 3347, 10.1093/hmg/ddt183 Menard, 2014, Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance, J. allergy Clin. Immunol., 133, 1149, 10.1016/j.jaci.2013.10.051 Chen, 2015, RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population, BMC Med. Genet., 16, 11, 10.1186/s12881-015-0150-9 Szymanski, 2012, The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population, Tissue Antigens, 79, 380, 10.1111/j.1399-0039.2012.01854.x Brown, 2014, Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci, J. Clin. Endocrinol. Metab., 99, E1387, 10.1210/jc.2013-4358 Simmonds, 2006, Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74, Clin. Endocrinol., 65, 429, 10.1111/j.1365-2265.2006.02586.x Krikos, 1992, Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements, J. Biol. Chem., 267, 17971, 10.1016/S0021-9258(19)37138-8 Song, 2014, Polymorphisms of the TNFAIP3 region and Graves' disease, Autoimmunity, 47, 459, 10.3109/08916934.2014.914504 Ban, 2008, Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease, J. Clin. Endocrinol. Metab., 93, 3589, 10.1210/jc.2008-0364 Medici, 2014, Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease, PLoS Genet., 10, e1004123, 10.1371/journal.pgen.1004123 Tomer, 2015, Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes, J. Autoimmun., 60, 32, 10.1016/j.jaut.2015.03.006 Jiang, 2003, Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155, J. Biol. Chem., 278, 27652, 10.1074/jbc.M302945200 Chen, 2015, Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease, Gene, 567, 154, 10.1016/j.gene.2015.04.074 Inal, 2015, Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Behcet's disease, Rheumatol. Int., 35, 837, 10.1007/s00296-014-3171-3 Vaidya, 2000, Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease, J. Clin. Endocrinol. Metab., 85, 688 Downie-Doyle, 2006, Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome, Arthritis Rheum., 54, 2434, 10.1002/art.22004 Lee, 2005, CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis, Hum. Genet., 116, 361, 10.1007/s00439-004-1244-1 Huang, 1998, Genetic association of Ctla-4 to myasthenia gravis with thymoma, J. Neuroimmunol., 88, 192, 10.1016/S0165-5728(98)00119-2 Djilali-Saiah, 1998, CTLA-4 gene polymorphism is associated with predisposition to coeliac disease, Gut, 43, 187, 10.1136/gut.43.2.187 Agarwal, 2000, CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis, J. Hepatol., 32, 538, 10.1016/S0168-8278(00)80213-5 Song, 2013, The CTLA-4 and MCP-1 polymorphisms and susceptibility to systemic sclerosis: a meta-analysis, Immunol. Invest., 42, 481, 10.3109/08820139.2013.789910 Velaga, 2004, The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease, J. Clin. Endocrinol. Metab., 89, 5862, 10.1210/jc.2004-1108 Bottini, 2004, A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes, Nat. Genet., 36, 337, 10.1038/ng1323 Carlton, 2005, PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis, Am. J. Hum. Genet., 77, 567, 10.1086/468189 Kyogoku, 2004, Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE, Am. J. Hum. Genet., 75, 504, 10.1086/423790 Chistiakov, 2007, Is FCRL3 a new general autoimmunity gene?, Hum. Immunol., 68, 375, 10.1016/j.humimm.2007.01.013 Wang, 2015, Significant association between Fc receptor-like 3 polymorphisms (-1901A>G and -658C>T) and neuromyelitis optica (NMO) susceptibility in the chinese population, Mol. Neurobiol. Li, 2008, Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet's disease in a Chinese population with ophthalmic manifestations, Mol. Vis., 14, 2136 Yuan, 2015, Four FCRL3 gene polymorphisms (FCRL3_3, _5, _6, _8) confer susceptibility to multiple sclerosis: results from a case-control study, Mol. Neurobiol. Svejgaard, 1983, HLA and disease 1982 – a survey, Immunol. Rev., 70, 193, 10.1111/j.1600-065X.1983.tb00715.x Todd, 1988, A molecular basis for MHC class II–associated autoimmunity, Science, 240, 1003, 10.1126/science.3368786